|

ABX-002 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 2: 2

Top Sponsors

  • Autobahn Therapeutics, Inc.2

Indications

  • Depression2
  • Bipolar Disorder Depression1
  • Major Depressive Disorder1

Birmingham, Alabama1 trial

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

Autobahn Site #131

Phase 2

Walnut Creek, California1 trial

Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults

Autobahn Site #213

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.